Histaminic bronchospasm potentiated by adenosine: investigation of the mechanisms

European Journal of Pharmacology
P NieriM C Breschi


In anaesthetized guinea pigs, adenosine enhances the histamine-induced bronchospasm by means of a mechanism partly involving non-adrenergic-non-cholinergic (NANC) nerves, not related to capsaicin-sensitive neurons (Breschi et al., 1994). In the present paper, we excluded any interference by adenosine with the mediators known to be present in the airway inhibitory NANC system, VIP (vasoactive intestinal polypeptide) and NO (nitric oxide). The use of alpha-chymotrypsin or L-N(G)-nitro-arginine methyl ester (L-NAME) failed to modify the potentiation under study. The effects of adenosine were further investigated by studying whether an increased release of excitatory mediators from non-neural cells, in particular 5-HT (5-hydroxytryptamine, serotonin) and arachidonic products, was involved. In this connection, methysergide did not significantly affect the modulatory action of adenosine, revealing that the release of 5-HT was also not involved. Inhibition was obtained with hydrocortisone and with nordihydroguaiaretic acid, but not with indomethacin or with the mastocyte membrane stabilizer, sodium cromoglycate. This evidence suggests that lipooxygenase products, not derived from mastocytes, probably participate in the potentiating ef...Continue Reading


Aug 14, 2012·Pharmacological Reviews·Geoffrey BurnstockJean-Pierre Timmermans


Dec 1, 1975·The Journal of Allergy and Clinical Immunology·J B Richardson, T Bouchard
Aug 1, 1992·British Journal of Pharmacology·J R Thorne, K J Broadley
Jan 3, 1990·European Journal of Pharmacology·D F Biggs, R C Ladenius
Nov 15, 1990·Biochemical and Biophysical Research Communications·M Di RosaS Moncada
May 1, 1991·The American Review of Respiratory Disease·A G DriverS J Mustafa
Feb 1, 1990·The American Review of Respiratory Disease·Y Sibille, H Y Reynolds
Aug 1, 1987·The American Review of Respiratory Disease·R A Pauwels, M E Van der Straeten
May 1, 1985·British Journal of Clinical Pharmacology·J S Mann, S T Holgate
Dec 1, 1970·Acta Allergologica·B Elgefors, H Formgren
Dec 1, 1967·European Journal of Pharmacology·M W McCullochM J Rand
Feb 1, 1983·British Journal of Clinical Pharmacology·M J CushleyS T Holgate
Nov 1, 1983·Circulation Research·R F Furchgott
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P F WellerR A Lewis
Apr 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·C R MartlingJ M Lundberg
Feb 1, 1982·Prostaglandins, Leukotrienes, and Medicine·J L CopasP J Gardiner
Mar 1, 1993·British Journal of Pharmacology·K IshidaR R Schellenberg
Apr 1, 1996·The Journal of Pharmacy and Pharmacology·P NieriM C Breschi
Jun 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A A Norris

Related Concepts

Histamine Measurement
Respiratory Tract Structure
Mast Cell
Serotonin Measurement
Receptor Down-Regulation

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.